Aytu Biopharma, Inc. AYTU
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -1.52% | -11.02% | -7.98% | 5.42% | 70.32% |
| Total Receivables | -6.98% | -20.81% | -6.93% | 6.64% | -13.04% |
| Inventory | -8.04% | -13.82% | -14.30% | -11.67% | 3.40% |
| Prepaid Expenses | -32.88% | 30.51% | 28.77% | -8.58% | -24.38% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -8.27% | -11.69% | -6.00% | 2.44% | 9.19% |
|
|
|||||
| Total Current Assets | -8.27% | -11.69% | -6.00% | 2.44% | 9.19% |
| Net Property, Plant & Equipment | -5.69% | -8.73% | -4.44% | -5.21% | -3.86% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -2.56% | -2.50% | 5.18% | -1.83% | -13.36% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.09% | -24.66% | -21.41% | -22.01% | -8.86% |
| Total Assets | -5.98% | -8.45% | -2.39% | 0.65% | -0.02% |
|
|
|||||
| Total Accounts Payable | -14.61% | -7.33% | 15.53% | 16.42% | -11.96% |
| Total Accrued Expenses | 5.56% | -19.13% | 2.22% | 6.47% | -13.66% |
| Short-term Debt | -41.66% | 14.72% | -38.98% | 64.11% | -9.62% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.92% | 0.19% | -0.19% | 3.26% | 1.79% |
| Total Finance Division Other Current Liabilities | 0.90% | -11.50% | 15.12% | -21.71% | -9.85% |
| Total Other Current Liabilities | 0.90% | -11.50% | 15.12% | -21.71% | -9.85% |
| Total Current Liabilities | -8.86% | -8.53% | -0.65% | 4.64% | -10.81% |
|
|
|||||
| Total Current Liabilities | -8.86% | -8.53% | -0.65% | 4.64% | -10.81% |
| Long-Term Debt | -4.69% | -4.49% | -4.30% | -4.11% | 14.26% |
| Short-term Debt | -41.66% | 14.72% | -38.98% | 64.11% | -9.62% |
| Capital Leases | -7.18% | -5.55% | -4.89% | 3.86% | -1.60% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -16.15% | -80.47% | 28.38% | -19.54% | 275.47% |
| Total Liabilities | -8.90% | -28.99% | 5.88% | -3.23% | 17.81% |
|
|
|||||
| Common Stock & APIC | 0.04% | 7.45% | 0.45% | 0.64% | 1.11% |
| Retained Earnings | 0.00% | -1.64% | -3.19% | 0.59% | -6.32% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 0.37% | 147.47% | -38.71% | 22.17% | -45.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 0.37% | 147.47% | -38.71% | 22.17% | -45.65% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 0.37% | 147.47% | -38.71% | 22.17% | -45.65% |
|
|
|||||